ACCESSION: MSBNK-SMB_Measured-HSA001P0199025
RECORD_TITLE: Uncharacterized; LC-ESI-QFT; MS2; POSITIVE; Averaged data
DATE: 2025.04.02 (Averaged 2025.02.17, Processed 2025.02.17, Annotated 2025.03.05, Curated 2025.04.02)
AUTHORS: Shin-MassBank project
LICENSE: CC BY-NC-SA
PUBLICATION: Shin-MassBank project in preparation
COMMENT: This is an averaged mass spectra data created by averaging product ion scan data obtained from the following DDA dataset.
COMMENT: REPOSITORY MB-POST
COMMENT: DATASET_ID MPST000004
COMMENT: DATASET_TITLE Annotation of various metabolites in SRM 1950 human serum
COMMENT: DATASET_AUTHORS Masatomo Takahashi, Yoshihiro Izumi, Kyoshu University
COMMENT: MS1_M/Z_AVERAGED_THRES 0.750
COMMENT: MS2_M/Z_AVERAGED_THRES 4.000
COMMENT: DATASET_FILE_NUM 22
COMMENT: NUM_AVERAGED_SPEC 22
COMMENT: RAW_SPEC {'16_posi_514': {'bp': 579952.0, 'sum': 2042777.0}, '6_posi_513': {'bp': 381139.0, 'sum': 1624453.0}, '11_posi_513': {'bp': 462770.0, 'sum': 1789368.0}, '19_posi_1081': {'bp': 157583.0, 'sum': 876374.0}, '8_posi_512': {'bp': 280426.0, 'sum': 1442588.0}, '3_posi_513': {'bp': 383740.0, 'sum': 1701205.0}, '14_posi_514': {'bp': 384866.0, 'sum': 1593292.0}, '15_posi_512': {'bp': 419098.0, 'sum': 1803356.0}, '12_posi_513': {'bp': 431142.0, 'sum': 1692918.0}, '13_posi_493': {'bp': 249018.0, 'sum': 1336568.0}, '19_posi_1208': {'bp': 164377.0, 'sum': 934034.0}, '9_posi_515': {'bp': 365377.0, 'sum': 1542891.0}, '7_posi_512': {'bp': 303194.0, 'sum': 1457142.0}, '10_posi_514': {'bp': 356535.0, 'sum': 1522798.0}, '19_posi_1144': {'bp': 171607.0, 'sum': 1003643.0}, '17_posi_514': {'bp': 533752.0, 'sum': 2017628.0}, '5_posi_514': {'bp': 363440.0, 'sum': 1563233.0}, '4_posi_514': {'bp': 315580.0, 'sum': 1448433.0}, '1_posi_512': {'bp': 382987.0, 'sum': 1595037.0}, '19_posi_453': {'bp': 158211.0, 'sum': 869488.0}, '2_posi_512': {'bp': 339747.0, 'sum': 1699716.0}, 'ProcedureBlank_1206': {'bp': 194813.0, 'sum': 1067857.0}}
COMMENT: RETENTION_TIME_STDEV 0.517
COMMENT: PRECURSOR_M/Z_RAW 199.180133
COMMENT: PRECURSOR_M/Z_STDEV 0.000038
COMMENT: PRECURSOR_IN_MS1 mz 199.180461; int 130.662; delta(ppm) 0.976093
COMMENT: PROPOSED_CHARGE_STATE +1; mz 200.183620; int 15.630; cor 0.839
COMMENT: PROPOSED_ISOTOPE_STATE ND
COMMENT: PROPOSED_MAX_NUM_S 0
COMMENT: PROPOSED_MF SevenGoldenRules 0.146; C11H22N2O; [M+H]+; delta(ppm) -0.146337
COMMENT: PROPOSED_MF MS-FINDER 2.877; C11H22N2O; [M+H]+; delta(ppm) -0.149465
COMMENT: PROPOSED_MF SIRIUS5_Sirius 52.298; C11H22N2O; [M+H]+; delta(ppm) -0.149465
COMMENT: PROPOSED_MF SIRIUS5_Zodiac 1.000; C11H22N2O; [M+H]+; delta(ppm) -0.149465
COMMENT: PROPOSED_MF SIRIUS6_Sirius 76.389; C11H22N2O; [M+H]+; delta(ppm) -0.149465
COMMENT: PROPOSED_MF SIRIUS6_Sirius 60.648; C9H20N5; [M+H]+; delta(ppm) 6.591519
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 1.000; C11H22N2O; [M+H]+; delta(ppm) -0.149465
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.772; VAUQXPBOGCJNHH-UHFFFAOYSA-N; [M+H]+; {1-[(1-methylpyrrolidin-2-yl)methyl]pyrrolidin-2-yl}methanol
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.664; DQZCVNGCTZLGAQ-UHFFFAOYSA-N; [M+H]+; Cycluron
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.664; BHZUVJBGWCDHJI-UHFFFAOYSA-N; [M+H]+; N,N-dimethyl-1-(2-methylpropyl)pyrrolidine-3-carboxamide
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.664; VDPIXLIWEGEOGP-UHFFFAOYSA-N; [M+H]+; N-methyl-N-[1-(2-methylpropyl)pyrrolidin-3-yl]acetamide
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.634; ROHPOJQPAAMVIN-UHFFFAOYSA-N; [M+H]+; 8-ethyl-8-methyl-9-oxa-1,4-diazaspiro[5.5]undecane
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.621; OKVPXXXRKDJWQI-UHFFFAOYSA-N; [M+H]+; N-{[ethenyl(propan-2-yl)amino]methyl}-N-(propan-2-yl)acetamide
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.598; HVXYQAREJSKQNE-UHFFFAOYSA-N; [M+H]+; N-(2,2,6,6-tetramethylpiperidin-4-yl)acetamide
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.533; LWCZGAZGRBEYRS-UHFFFAOYSA-N; [M+H]+; 1,3,5,7-tetramethyl-3,7-diazabicyclo[3.3.1]nonan-9-ol
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; OKVPXXXRKDJWQI-UHFFFAOYSA-N; [M+H]+; N-{[ethenyl(propan-2-yl)amino]methyl}-N-(propan-2-yl)acetamide
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.989; DQZCVNGCTZLGAQ-UHFFFAOYSA-N; [M+H]+; Cycluron
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.730; VAUQXPBOGCJNHH-UHFFFAOYSA-N; [M+H]+; {1-[(1-methylpyrrolidin-2-yl)methyl]pyrrolidin-2-yl}methanol
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.657; VDPIXLIWEGEOGP-UHFFFAOYSA-N; [M+H]+; N-methyl-N-[1-(2-methylpropyl)pyrrolidin-3-yl]acetamide
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.652; BHZUVJBGWCDHJI-UHFFFAOYSA-N; [M+H]+; N,N-dimethyl-1-(2-methylpropyl)pyrrolidine-3-carboxamide
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.639; ROHPOJQPAAMVIN-UHFFFAOYSA-N; [M+H]+; 8-ethyl-8-methyl-9-oxa-1,4-diazaspiro[5.5]undecane
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.487; HVXYQAREJSKQNE-UHFFFAOYSA-N; [M+H]+; N-(2,2,6,6-tetramethylpiperidin-4-yl)acetamide
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.382; LWCZGAZGRBEYRS-UHFFFAOYSA-N; [M+H]+; 1,3,5,7-tetramethyl-3,7-diazabicyclo[3.3.1]nonan-9-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 3.059; DQZCVNGCTZLGAQ-UHFFFAOYSA-N; [M+H]+; 3-cyclooctyl-1,1-dimethylurea
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.810; HVXYQAREJSKQNE-UHFFFAOYSA-N; [M+H]+; N-(2,2,6,6-tetramethylpiperidin-4-yl)acetamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.345; COLUTWBYJCLQKO-UHFFFAOYSA-N; [M+H]+; 1-tert-butyl-3-cyclohexylurea
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.211; IMQRZUQNVVBHHS-UHFFFAOYSA-N; [M+H]+; 4-(2-pyrrolidin-1-ylethoxy)piperidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.168; ZNADTBMMQHPLQF-UHFFFAOYSA-N; [M+H]+; 3-cyclohexyl-1,1-diethylurea
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.142; NTLOVUMPYFDNSG-UHFFFAOYSA-N; [M+H]+; 2-amino-N-cyclohexyl-3-methylbutanamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.114; VUEUCIYETAXEGY-UHFFFAOYSA-N; [M+H]+; 1-(azepan-1-yl)-2-(propan-2-ylamino)ethanone
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.111; WXGLFUSDLRRYFE-UHFFFAOYSA-N; [M+H]+; 1-(2-pyrrolidin-3-yloxyethyl)piperidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.103; LTIKAHOLVVSRIT-UHFFFAOYSA-N; [M+H]+; 1-amino-N,N-diethylcyclohexane-1-carboxamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.102; NBGFXXIMKJNWMF-UHFFFAOYSA-N; [M+H]+; N-methyl-2-piperidin-4-yl-N-propan-2-ylacetamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.011; ZUQYRNJZPLAUMM-UHFFFAOYSA-N; [M+H]+; 1-heptan-4-yl-3-prop-2-enylurea
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.002; MMPLEHAWGGNIRY-UHFFFAOYSA-N; [M+H]+; 1-(piperazin-1-ylmethyl)cyclohexan-1-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.998; ARYKQGBMGGVEDY-UHFFFAOYSA-N; [M+H]+; N-(propan-2-ylideneamino)-2-propylpentanamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.990; PLFCUQQRXRYJPJ-UHFFFAOYSA-N; [M+H]+; 1-butyl-3-cyclohexylurea
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.989; FRCQVIXJQKSHHF-UHFFFAOYSA-N; [M+H]+; 1-(morpholin-4-ylmethyl)cyclohexan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.984; JNXNNHVJXOJOAD-UHFFFAOYSA-N; [M+H]+; 1-butan-2-yl-3-cyclohexylurea
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.972; KSXZTCUHMYITTO-UHFFFAOYSA-N; [M+H]+; 1-cyclohexyl-3-(2-methylpropyl)urea
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.950; GOQVOSCJGILEEX-UHFFFAOYSA-N; [M+H]+; N,N-diethyl-1-methylpiperidine-3-carboxamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.932; WXHNLQJZJOWHJB-UHFFFAOYSA-N; [M+H]+; 2-(2-hexyl-4,5-dihydroimidazol-1-yl)ethanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.918; YWDIUQYPFNPADD-UHFFFAOYSA-N; [M+H]+; N-butyl-N-methylpiperidine-4-carboxamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.884; MCIDPQNLGSHVEJ-UHFFFAOYSA-N; [M+H]+; (1-morpholin-4-ylcyclohexyl)methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.824; ZAWQTXGUPNQHBV-UHFFFAOYSA-N; [M+H]+; 1-methyl-4-piperidin-4-yloxypiperidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.804; VAUQXPBOGCJNHH-QWRGUYRKSA-N; [M+H]+; [(2S)-1-[[(2S)-1-methylpyrrolidin-2-yl]methyl]pyrrolidin-2-yl]methanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.787; JOBGQESUECMKSS-UHFFFAOYSA-N; [M+H]+; 4-[(4-methylpiperidin-4-yl)methyl]morpholine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.755; RZZMYIRPKVMLDC-UHFFFAOYSA-N; [M+H]+; 2-(4-aminopiperidin-1-yl)cyclohexan-1-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.752; WOKKNFFPTWTAME-UHFFFAOYSA-N; [M+H]+; 1-(4-methoxycyclohexyl)piperazine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.742; DSIZCPZVGIMIFI-UHFFFAOYSA-N; [M+H]+; N-(4-aminocyclohexyl)-2,2-dimethylpropanamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.736; FXCPLDHPNOXGOM-UHFFFAOYSA-N; [M+H]+; 1,3-dibutylimidazolidin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.713; MYYJFAYHVMWIDI-AOOOYVTPSA-N; [M+H]+; (2R,6S)-2,6-dimethyl-4-piperidin-4-ylmorpholine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.711; RWRJHGLVBDUGIM-QWRGUYRKSA-N; [M+H]+; [(1S,2S)-2-morpholin-4-ylcyclohexyl]methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.706; ATFSZHZPWJAUHO-UHFFFAOYSA-N; [M+H]+; 1-(1-morpholin-4-ylcyclopentyl)ethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.690; UBGGREWUFINDKK-UHFFFAOYSA-N; [M+H]+; 1-(2,2,4,6-tetramethylpiperazin-1-yl)propan-1-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.675; WCWNHWJGSIEEBV-UHFFFAOYSA-N; [M+H]+; 1-(4-aminopiperidin-1-yl)-2-ethylbutan-1-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.635; PEQIEMJCOKSLBT-UHFFFAOYSA-N; [M+H]+; (1-piperidin-4-ylpiperidin-3-yl)methanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.635; RXOOHWWWEUJXME-UHFFFAOYSA-N; [M+H]+; 4-[2-(dimethylamino)ethyl-methylamino]cyclohexan-1-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.500; WPRDDJXDDYCXFJ-UHFFFAOYSA-N; [M+H]+; 1-(oxan-4-ylmethyl)piperidin-4-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.470; CSDOMXCPKBRBKJ-UHFFFAOYSA-N; [M+H]+; 8-(2-methoxyethyl)-N-methyl-8-azabicyclo[3.2.1]octan-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.468; CNAWWTRDALPJDO-UHFFFAOYSA-N; [M+H]+; [1-(oxan-4-yl)piperidin-4-yl]methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.437; PNFYNBBBJIYYNV-UHFFFAOYSA-N; [M+H]+; N-methyl-1-(oxolan-3-ylmethyl)piperidin-4-amine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -39.808; ZNADTBMMQHPLQF; [M+H]+; 1-cyclohexyl-3,3-diethylurea
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -54.274; PLFCUQQRXRYJPJ; [M+H]+; 1-butyl-3-cyclohexylurea
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -61.603; COLUTWBYJCLQKO; [M+H]+; 1-tert-butyl-3-cyclohexylurea
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -62.986; DQZCVNGCTZLGAQ; [M+H]+; Cyclouron
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -67.791; JNXNNHVJXOJOAD; [M+H]+; 1-butan-2-yl-3-cyclohexylurea
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -132.228; FXCPLDHPNOXGOM; [M+H]+; N,N''-Dibutylethyleneurea
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -155.462; GASMLRFTKRLWLW; [M+H]+; N-butyl(4-methylpiperidyl)carboxamide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -158.648; ZUQYRNJZPLAUMM; [M+H]+; 1-Allyl-3-(4-heptyl)urea
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -203.509; VDPIXLIWEGEOGP; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -220.027; HVXYQAREJSKQNE; [M+H]+; Oprea1_681306
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -265.367; KKNUQYWVTTUVJX; [M+H]+; 2-methyl-N-[2-(pentan-3-ylamino)ethyl]prop-2-enamide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -271.841; BHZUVJBGWCDHJI; [M+H]+; N,N-dimethyl-1-(2-methylpropyl)pyrrolidine-3-carboxamide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -272.436; VAUQXPBOGCJNHH; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -274.958; MCIDPQNLGSHVEJ; [M+H]+; (1-morpholinocyclohexyl)methanamine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -284.529; OKVPXXXRKDJWQI; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -292.104; ROHPOJQPAAMVIN; [M+H]+; Oprea1_273710
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -306.588; WXHNLQJZJOWHJB; [M+H]+; 1-Hydroxyethyl-2-hexylimidazoline
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -311.765; QGWQHDWECZBDTR; [M+H]+; 10-undecenohydrazide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -315.136; BYXHXBCFNMHZGY; [M+H]+; N-(3-(Dimethylamino)-2,2-dimethylpropyl)methacrylamide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -315.582; UBGGREWUFINDKK; [M+H]+; 1-Propionyl-2,2,4,6-tetramethyl piperazine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -321.183; ARYKQGBMGGVEDY; [M+H]+; N''-Isopropylidene dipropylacetohydrazide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -333.719; GOQVOSCJGILEEX; [M+H]+; N,N-Diethyl-1-methylnipecotamide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -376.407; LWCZGAZGRBEYRS; [M+H]+; Oprea1_487414
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -389.347; HZGQVBNAYNHMPZ; [M+H]+; 2-Butoxy-2-propenylidene methanaminium
COMMENT: PROPOSED_COMPOUND SIRIUS5_Confidence:biodatabase 0.499; ZNADTBMMQHPLQF; [M+H]+; 1-cyclohexyl-3,3-diethylurea
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -65.965; ZNADTBMMQHPLQF; [M+H]+; 3-Cyclohexyl-1,1-diethylurea
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -74.543; PLFCUQQRXRYJPJ; [M+H]+; 1-Butyl-3-cyclohexylurea
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -85.246; KSXZTCUHMYITTO; [M+H]+; 1-Cyclohexyl-3-isobutylurea
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -86.319; COLUTWBYJCLQKO; [M+H]+; N-(tert-butyl)-N'-cyclohexylurea
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -89.799; JNXNNHVJXOJOAD; [M+H]+; N-(Sec-butyl)-N'-cyclohexylurea
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -118.357; DQZCVNGCTZLGAQ; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -145.166; FXCPLDHPNOXGOM; [M+H]+; 2-Imidazolidinone, 1,3-dibutyl-
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -199.881; ZUQYRNJZPLAUMM; [M+H]+; Urea, 1-allyl-3-(4-heptyl)-
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -201.383; OKVPXXXRKDJWQI; [M+H]+; N-{[ethenyl(propan-2-yl)amino]methyl}-N-(propan-2-yl)acetamide
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -201.979; GASMLRFTKRLWLW; [M+H]+; N-butyl-4-methylpiperidine-1-carboxamide
COMMENT: PROPOSED_COMPOUND SIRIUS6_Confidence:biodatabase 0.627; ZNADTBMMQHPLQF; [M+H]+; 3-Cyclohexyl-1,1-diethylurea
COMMENT: CONFIDENCE Level 4: Unequivocal precursor ion formula C11H23N2O1; Top hit by both SIRIUS6_Zodiac and MS-FINDER; and SevenGoldenRules(1), SIRIUS5_Sirius(1), SIRIUS5_Zodiac(1);
CH$NAME: Uncharacterized
CH$COMPOUND_CLASS: Uncharacterized
CH$FORMULA: C39H42O2
CH$EXACT_MASS: 542.318480
CH$SMILES: CCCC#Cc1cc(C#CCCC)cc(C#Cc2cc(C#CC(C)(C)C)c(cc2C#CC(C)(C)C)C2OCCO2)c1
CH$IUPAC: InChI=1S/C39H42O2/c1-9-11-13-15-30-25-31(16-14-12-10-2)27-32(26-30)17-18-33-28-35(20-22-39(6,7)8)36(37-40-23-24-41-37)29-34(33)19-21-38(3,4)5/h25-29,37H,9-12,23-24H2,1-8H3
CH$LINK: PUBCHEM CID:11353257
SP$SCIENTIFIC_NAME: Homo sapiens
SP$LINK: NCBI-TAXONOMY 9606 
SP$SAMPLE: Serum
AC$INSTRUMENT: Nexera X2 UHPLC system, Shimadzu - Q Exactive Orbitrap, Thermo Scientific
AC$INSTRUMENT_TYPE: LC-ESI-QFT
AC$MASS_SPECTROMETRY: MS_TYPE MS2
AC$MASS_SPECTROMETRY: ION_MODE POSITIVE
AC$MASS_SPECTROMETRY: COLLISION_ENERGY 20 V
AC$MASS_SPECTROMETRY: COLLISION_GAS N2
AC$MASS_SPECTROMETRY: FRAGMENTATION_MODE CID
AC$MASS_SPECTROMETRY: ION_SPRAY_VOLTAGE 4.0 kV
AC$MASS_SPECTROMETRY: IONIZATION ESI
AC$MASS_SPECTROMETRY: MASS_ACCURACY MS1(ppm) 0.75; MS2(ppm) 4.00
AC$CHROMATOGRAPHY: COLUMN_NAME GL-HilicAex 2.1 x 150 mm, 5 mm (Resonac)
AC$CHROMATOGRAPHY: FLOW_GRADIENT B conc(%). 0 min: 95, 0.5 min: 95, 15.5 min: 40, 16.5 min: 0, 26.5 min: 0, 27.5 min: 95, 35 min: 95.
AC$CHROMATOGRAPHY: FLOW_RATE 0.4 mL/min
AC$CHROMATOGRAPHY: RETENTION_TIME 1.263
MS$FOCUSED_ION: PRECURSOR_M/Z 199.180460
MS$DATA_PROCESSING: RECALIBRATE Data dependent recalibration using whole DDA dataset
PK$SPLASH: splash10-0002-2900000000-6244368a77749c11d6c7
PK$ANNOTATION: m/z int m/z_nocal m/z_std(ppm) int_std cor n annotation
  69.0698946 108.4390 69.070520 0.6226 40.78 0.3710 22 f{C5H9}/0.26ppm,p-C6H14N2O1
  71.0603309 39.5565 71.060944 1.4213 14.12 0.3721 22 f{C3H7N2}/-0.62ppm,p-C8H16O1
  72.0443867 51.1315 72.044993 1.2909 12.85 0.8058 22 f{C3H6N1O1}/-0.05ppm,p-C8H17N1
  74.0964210 682.9361 74.097012 0.3779 36.41 0.9616 22 f{C4H12N1}/-0.06ppm,p-C7H11N1O1
  83.0855655 20.0397 83.086069 1.3841 4.17 0.7668 18 f{C6H11}/0.47ppm,p-C5H12N2O1
  85.0759640 32.5484 85.076443 1.4105 10.80 0.3755 22 f{C4H9N2}/-0.71ppm,p-C7H14O1
  86.0600260 73.6951 86.060493 1.1039 19.82 0.5618 22 f{C4H8N1O1}/-0.17ppm,p-C7H15N1
  87.0916678 30.1400 87.092121 1.6190 10.05 0.4410 22 f{C4H11N2}/-0.08ppm,p-C7H12O1
  100.0757098 233.4554 100.076031 0.5396 18.27 0.9582 22 f{C5H10N1O1}/0.19ppm,p-C6H13N1
  111.0553418 29.4716 111.055558 1.5398 13.74 0.1462 22 f{C5H7N2O1}/0.47ppm,p-C6H16
  111.0917308 56.3005 111.091946 1.0532 19.55 0.4229 22 f{C6H11N2}/0.50ppm,p-C5H12O1
  111.1168574 208.3977 111.117073 0.5220 74.14 0.4918 22 f{C8H15}/0.27ppm,p-C3H8N2O1
  113.0710297 22.8761 113.071223 2.3702 6.27 0.6221 21 f{C5H9N2O1}/0.80ppm,p-C6H14
  114.1026232 110.0732 114.102805 0.9378 22.29 0.5392 22 ?
  115.0866091 40.7996 115.086780 1.4424 12.55 0.7053 22 f{C5H11N2O1}/0.17ppm,p-C6H12
  117.1022638 21.3271 117.102410 1.7933 3.65 0.8456 19 f{C5H13N2O1}/0.21ppm,p-C6H10
  127.1105160 33.9877 127.110528 1.5892 14.34 -0.0130 22 ?
  128.0819040 21.9707 128.081902 2.2954 7.93 0.2812 20 ?
  129.0661016 19.3815 129.066085 3.0372 8.52 0.0052 18 ?
  129.1023267 33.8913 129.102309 2.1069 11.79 0.3442 21 f{C6H13N2O1}/0.68ppm,p-C5H10
  138.0662491 17.0462 138.066155 2.6437 6.81 0.2892 17 ?
  139.0867308 22.8012 139.086636 1.6465 6.86 0.5727 21 f{C7H11N2O1}/1.02ppm,p-C4H12
  140.0816927 17.9691 140.081597 2.7341 8.01 0.1068 20 ?
  141.0295789 20.3962 141.029483 2.6377 8.54 0.1882 16 ?
  153.1135836 19.3549 153.113479 2.3055 9.68 -0.1579 18 ?
  154.0975498 57.3199 154.097445 1.6094 24.40 0.1925 22 ?
  158.0559938 45.2088 158.055886 1.7525 13.61 0.6352 22 ?
  158.1539810 71.1356 158.153874 2.3458 27.62 0.5268 22 f{C9H20N1O1}/0.26ppm,p-C2H3N1
  181.1089020 85.7166 181.108780 1.7779 25.53 0.5878 22 ?
  181.1447035 248.0421 181.144581 0.5410 87.51 0.4241 22 f{C11H19N1O1}/-7.80ppm,p-H4N1
  182.0927654 39.9728 182.092643 1.5706 13.27 0.4896 22 ?
  182.1289845 25.6551 182.128862 1.8064 13.14 -0.1372 22 ?
  199.1193971 244.7589 199.119264 1.6874 67.43 0.4078 21 ?
  199.1556616 750.0477 199.155528 0.9339 177.91 0.4794 22 ?
  199.1808598 999.0000 199.180726 0.9137 28.97 1.0000 22 f{C11H23N2O1}/1.86ppm,p
PK$NUM_PEAK: 35
PK$PEAK: m/z int. rel.int.
  69.069895 108.44 108
  71.060331 39.56 39
  72.044387 51.13 51
  74.096421 682.94 682
  83.085566 20.04 20
  85.075964 32.55 32
  86.060026 73.70 73
  87.091668 30.14 30
  100.075710 233.46 233
  111.055342 29.47 29
  111.091731 56.30 56
  111.116857 208.40 208
  113.071030 22.88 22
  114.102623 110.07 110
  115.086609 40.80 40
  117.102264 21.33 21
  127.110516 33.99 33
  128.081904 21.97 21
  129.066102 19.38 19
  129.102327 33.89 33
  138.066249 17.05 17
  139.086731 22.80 22
  140.081693 17.97 17
  141.029579 20.40 20
  153.113584 19.35 19
  154.097550 57.32 57
  158.055994 45.21 45
  158.153981 71.14 71
  181.108902 85.72 85
  181.144703 248.04 248
  182.092765 39.97 39
  182.128984 25.66 25
  199.119397 244.76 244
  199.155662 750.05 750
  199.180860 999.00 999
//
